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Background
Th e mammary gland is a highly dynamic tissue, under-
going signiﬁ cant morphological change during puberty, 
pregnancy, lactation and involution. Flow cytometry 
using multiple markers has enabled the prospective 
isolation of mammary epithelial subpopulations suggest-
ing a hierarchical organisation of stem, progenitor and 
diﬀ erentiated cells. Utilising the cleared mammary fat 
pad transplantation assay, developed from the pio-
neering work of Deome and colleagues [1], mammary 
stem cells (MaSCs) have been deﬁ ned as highly enriched 
in the CD24+/LowSca1–CD49fHighCD29High population 
[2-5]. A single cell from this population is able to 
recapitulate the entire gland upon trans plantation [3,5], 
showing deﬁ ning stem cell charac teristics of multi-
diﬀ erentiative potential and self-renewal. Despite much 
work to deﬁ ne factors necessary for MaSC function, 
molecular mechanisms regu lating MaSCs are poorly 
deﬁ ned. Epithelial–mesen chymal transition (EMT), a key 
developmental programme in the embryo that confers 
mesenchymal cell traits on epithelial cells, has recently 
been linked to the MaSC state [6,7]. EMT has also been 
implicated in tumour invasion and metastasis, and a 
potential role in self-renewal strengthens known 
associations between normal tissue stem cells and cancer 
cells [8].
Despite ongoing controversy over the existence and 
origin of cancer cells, the cancer stem cell model – in 
which tumours are maintained by a population of stem-
like cancer cells – provides an attractive framework to 
understand metastatic potential and tumour hetero-
geneity in response to treat ment. Irrespective of the 
origins of these cells, their exact nature and nomenclature 
and their operational detection, it is unlikely that 
neoplastic (stem-like) cell populations invent a novel 
programme to drive their sustained proliferation. Instead, 
cancer cells adopt the self-renewal programme active in 
the antecedent stem cell population and exploit this to 
organise the complex tissues observed at various stages 
of neoplastic progression. Delineating the molecular 
factors that deﬁ ne the mammary epithelial cell hierarchy 
and maintain the MaSC state is therefore an important 
step towards under standing both normal development 
and tumouri genesis.
Slug and Sox9 as master regulators of the 
mammary stem cell state
A recent study by Guo and colleagues identiﬁ ed two 
master transcriptional regulators of the mammary stem 
cell state: the EMT-associated transcription factor Slug, 
and the SRY-box transcription factor Sox9 [9]. Ectopic 
co-expression of Slug and Sox9 in primary mouse 
mammary cells in vitro for 5 days was suﬃ  cient to 
convert diﬀ erentiated luminal cells into MaSCs, as demon-
strated by a competitive cleared mammary fat pad trans-
plantation assay. Diﬀ erentiated luminal cells expressing 
Slug and Sox9 were able to reconstitute the entire 
mammary gland upon serial transplantation, exhibiting 
deﬁ ning stem cell characteristics of multi-potency and 
self-renewal. Th ese factors were shown to act co-
operatively as expression of each factor individually was 
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not suﬃ  cient to confer stem cell traits on fully diﬀ er-
entiated cells.
Ectopic Sox9 expression alone in diﬀ erentiated cells 
produced cells with luminal progenitor characteristics, 
being able to proliferate in vitro and form hollow acini in 
three-dimensional culture conditions. Ectopic expression 
of Slug was able to convert luminal progenitor cells, 
which endogenously express Sox9, into cells with stem 
cell activity. In contrast, stem cell activity was enhanced 
in basal cells, which endogenously express Slug, by forced 
expression of Sox9. Interestingly, when Sox9 was ectopi-
cally expressed in basal cells at the same time as Slug was 
knocked down, the cells acquired a luminal progenitor-
like phenotype in vitro. Gene expression analysis of 
diﬀ erentiated cells ectopically expressing Slug or Sox9 
showed upregulation of basal or luminal progenitor-
associated genes, respectively, and both signatures were 
upregulated upon Slug/Sox9 co-expression. Th e authors 
postulated that Slug and Sox9 regulate basal and luminal 
lineage programmes, respectively. Each confers distinct 
biological properties on the cell, but both are required for 
MaSC function.
Given the important potential link between MaSCs and 
breast cancer stem cells, the study next looked at the 
eﬀ ects of Slug and Sox9 on tumour-initiating potential 
and metastasis. Th e human breast cancer cell line MDA-
MB-231 expresses both Slug and Sox9, forms tumours 
upon subcutaneous injection and metastasises to the 
lung upon tail vein injection into NOD/SCID mice. 
Knockdown of Sox9 reduced the tumour-initiating 
potential of the cells by over 70-fold following 
subcutaneous injection. In con trast, knockdown of Slug 
did not aﬀ ect tumour initiation but the resulting tumours 
were sixfold smaller than those in controls. In a 
metastasis assay, Slug or Sox9 knockdown reduced lung 
metastases by ﬁ vefold and 40-fold, respectively. In non-
metastatic MCF7ras human breast cancer cells implanted 
orthotopically into NOD/SCID mice, there was a 
signiﬁ cant increase in macrometastases from primary 
tumours ectopically co-expressing Slug and Sox9. Finally, 
in a tissue microarray of 306 clinical breast cancer 
samples, patients with primary tumours expressing high 
levels of both Slug and Sox9 had a signiﬁ cantly lower 
overall survival rate. Th e authors conclude that human 
breast cancer stem cells are controlled by the same 
master regulators governing the murine MaSC state.
Stem cell enhancement or altered cell fate?
Many studies have now demonstrated that transplanta-
tion potential in the cleared mammary fat pad assay is 
most highly enriched in the basal cell layer of the mammary 
epithelium [2-4]. If this transplantation potential can be 
serially propagated, we call this mammary epithelial stem 
cell potential. However, both the potential plasticity of 
the normal mammary epithelium and the inductive 
potential of the mammary environment are increasingly 
well recognised.
Th e work of Guo and colleagues is a very important 
step forward in understanding the molecular regulation 
of this plasticity and how it can promote mammary stem 
cell potential, but it will be diﬃ  cult to disentangle these 
phenomena. Slug promotes the basal phenotype when 
ectopically expressed in luminal progenitors. Sox9 pro-
motes luminal progenitor activity in diﬀ erentiated 
luminal cells and stem cell activity in diﬀ erentiated basal 
cells. Together, Slug and Sox9 determine stem cell-like 
activity in the mammary epithelium. Whether the basal 
phenotype is required for this activity (perhaps by 
determining response to the microenvironment) or 
whether changes in underlying self-renewal processes are 
independent of phenotypic changes remains unclear. 
Perhaps both scenarios are occurring, with Sox9 priming 
cellular self-renewal to respond to niche interactions that 
are made possible by the transcriptional programme 
driven by Slug activity.
Finally, as Guo and colleagues note themselves, in the 
mammary epithelium ‘basal’ does not necessarily mean 
‘stem cell’; and indeed the majority of basal mammary 
cells are not stem cells but rather are myoepithelial cells. 
Myoepithelial cells are, in terms of both function and 
identity, a cross between epithelial cells and mesenchymal 
cells and they express numerous EMT markers as part of 
their normal biology [10]. It is therefore wrong to 
characterise a luminal to basal phenotypic switch as 
EMT. Rather, expression of ‘mesenchymal markers’ is 
part of the normal diﬀ erentiative programme of the 
mammary epithelium, and this paper must be understood 
in that context.
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